Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma

By Chamberlain Marc   Johnston Sandra  

Journal of Neuro-Oncology, Vol. 91, Iss. 3, 2009-02 ,pp. : 359-367

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Hematologic Toxicity of Salvage Chemotherapy Following Stem Cell-Supported High-Dose Chemotherapy in Women with Recurrent Ovarian Cancer

By Cook S.   Penson R.   Duska L.   Nikrui N.   Goodman A.   Fuller A.   Seiden M.  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 48-54

Elsevier

Access to resources Recommend Favorite

Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with cisplatin-based chemotherapy

By Altundag Kadri   Aksoy Sercan   Gullu Ibrahim   Altundag Ozden   Ozyar Enis   Yalcin Suayib   Cengiz Mustafa   Akyol Fadil  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 211-215

Humana Press, Inc

Access to resources Recommend Favorite

Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors

By Feun Lynn   Marini Angela   Landy Howard   Markoe Arnold   Heros Deborah   Robles Carlos   Herrera Cristina   Savaraj Niramol  

Journal of Neuro-Oncology, Vol. 82, Iss. 2, 2007-04 ,pp. : 177-181

Springer Publishing Company

Access to resources Recommend Favorite

A Prospective Blinded Study of the Predictive Value of an Extreme Drug Resistance Assay in Patients Receiving CPT-11 for Recurrent Glioma

By Parker Ricardo J.   Fruehauf John P.   Mehta Rita   Filka Emese   Cloughesy Timothy  

Journal of Neuro-Oncology, Vol. 66, Iss. 3, 2004-02 ,pp. : 365-375

Springer Publishing Company

Access to resources Recommend Favorite